Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015251-25
Application #
6773954
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Plaut, Marshall
Project Start
1978-08-01
Project End
2007-10-31
Budget Start
2003-11-01
Budget End
2004-10-31
Support Year
25
Fiscal Year
2004
Total Cost
$374,263
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Behnecke, Anne; Li, Wei; Chen, Ling et al. (2009) IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor. J Allergy Clin Immunol 124:108-13
Zhang, Ke; Behnecke, Anne; Li, Wei et al. (2009) A novel multi-potential dendritic cell targeted gene vaccination platform; application to food allergy and beyond. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 96:338-47; discussion 348
Zhang, Ke; Zhu, Daocheng; Kepley, Christopher et al. (2007) Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy. Immunol Allergy Clin North Am 27:93-103
Kepley, Christopher L (2006) New approaches to allergen immunotherapy. Curr Allergy Asthma Rep 6:427-33
Zhu, Daocheng; Kepley, Christopher L; Zhang, Ke et al. (2005) A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 11:446-9
Kepley, Christopher L; Taghavi, Sharven; Mackay, Graham et al. (2004) Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J Biol Chem 279:35139-49